MDxHealth CEO Michael McGarrity Says We Expect To Reach The High End Of Our 2023 Revenue Guidance Of $65M-$70M, And Continue To Believe We Will Turn Profitable On An Adj. EBITDA Basis In H1 2025
Portfolio Pulse from Benzinga Newsdesk
MDxHealth CEO Michael McGarrity has stated that the company expects to reach the high end of its 2023 revenue guidance of $65M-$70M. Furthermore, the company believes it will turn profitable on an adjusted EBITDA basis in the first half of 2025.
November 08, 2023 | 11:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
MDxHealth's revenue is expected to reach the high end of its guidance by 2023, and the company is projected to become profitable by H1 2025.
The CEO's positive outlook on the company's future revenues and profitability is likely to instill confidence in investors, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100